Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NEOGENOMICS INC Director's Dealing 2011

May 20, 2011

32227_dirs_2011-05-20_de9d0f6d-7906-4a2f-bec2-b8bf51b3c7e1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NGNM.OB)
CIK: 0001077183
Period of Report: 2011-05-18

Reporting Person: SMITS MARK W (Chief Commercial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-05-18 Common Stock M 45000 $1.02 Acquired 45000 Direct
2011-05-18 Common Stock S 45000 $1.37 Disposed 0 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2011-05-18 Stock option (Right to Buy) $1.02 M 45000 Disposed 2015-08-30 Common Stock (45000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 6667 Direct

Footnotes

F1: On August 30, 2010 Mr. Smits was granted an option to purchase 425,000 shares of common stock. The first date that options became exercisable was August 30, 2010 and the remaining options vest based on time and performance based criteria.

F2: Mr. Smits has resigned his position with NeoGenomics, Inc. As a result he does not have any further beneficial ownership of derivative securities.